[The trial of the efficacy and safety of sequential therapy with Mexidol forte 250 in acute and early recovery stages of hemispheric ischemic stroke].

Autor: Loskutnikov MA; Magnitogorsk Irong&Steel Clinical Hospital, Magnitogorsk, Russia., Domashenko MA; Magnitogorsk Irong&Steel Clinical Hospital, Magnitogorsk, Russia., Vakin TM; Magnitogorsk Irong&Steel Clinical Hospital, Magnitogorsk, Russia., Trushina IA; Magnitogorsk Irong&Steel Clinical Hospital, Magnitogorsk, Russia., Konstantinov VI; Magnitogorsk Irong&Steel Clinical Hospital, Magnitogorsk, Russia., Proskuryakova OS; Magnitogorsk Irong&Steel Clinical Hospital, Magnitogorsk, Russia., Shchukina EP; Magnitogorsk Irong&Steel Clinical Hospital, Magnitogorsk, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2020; Vol. 120 (10), pp. 22-26.